Trademark Overview
On Thursday, April 1, 2004, a trademark application was filed for RECOLINX with the United States Patent and Trademark Office. The USPTO has given the RECOLINX trademark a serial number of 78394586. The federal status of this trademark filing is ABANDONED - EXPRESS as of Thursday, July 7, 2005. This trademark is owned by ZymoGenetics, Inc.. The RECOLINX trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, clotting agents, clotting preparations, and agents for converting and activating clotting polymers for use in the control of bleeding associated with a wide range of surgeries and trauma and bum injuries;materials for dressings, namely, surgical sponge, foam, gauze, or bioabsorbable polymers; pharmaceutical preparation for use in accelerating clotting time and arresting blood flow during medical procedures and treating blood disorders; preparations for use as a topical hemostat to control surgical bleeding, for the treatment of bleeding complications, trauma and burn injuries and to make alterations and enhancements in tissue repair; surgical preparations which are used locally or topically for hemostatic control in the form of sheets, flour, foam liquid and fabrics, absorbable surgical sponges and hemostats; pharmaceutical preparations
